These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8510001)

  • 1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flumazenil: US clinical pharmacology studies.
    Dunton AW; Schwam E; Pitman V; McGrath J; Hendler J; Siegel J
    Eur J Anaesthesiol Suppl; 1988; 2():81-95. PubMed ID: 2842144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.
    Preston KL; Wolf B; Guarino JJ; Griffiths RR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):707-20. PubMed ID: 1501118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.
    Saxon L; Borg S; Hiltunen AJ
    Pharmacol Biochem Behav; 2010 Aug; 96(2):148-51. PubMed ID: 20451546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the abuse potential of methocarbamol.
    Preston KL; Guarino JJ; Kirk WT; Griffiths RR
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1146-57. PubMed ID: 2703967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.
    Elliot EE; White JM
    Pharmacol Biochem Behav; 2000 Jun; 66(2):361-9. PubMed ID: 10880691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical dependence in baboons chronically treated with low and high doses of diazepam.
    Kaminski BJ; Sannerud CA; Weerts EM; Lamb RJ; Griffiths RR
    Behav Pharmacol; 2003 Jul; 14(4):331-42. PubMed ID: 12838039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam treatment for multiple ethanol withdrawals in mice.
    Becker HC; Veatch LM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice.
    Troisi 2nd JR; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1993 Jun; 4(3):217-230. PubMed ID: 11224189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):259-67. PubMed ID: 15452683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats.
    Gatch MB
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1736-43. PubMed ID: 10591589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil in alcohol withdrawal.
    Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
    Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.